EMBL Australia

His passion for regenerative medicine has seen him work all over the world and now Dr Harald Janovjak is bringing his expertise to EMBL Australia as a group leader based at the Australian Regenerative Medicine Institute at Monash University either later this year or in early 2018.

In collaboration with an assembly of highly recognised international scientists, EMBL Australia group leader Chen Davidovich and Nobel Laureate Thomas Cech (Howard Hughes Medical Institute and University of Colorado at Boulder) have discovered how a gene-suppressing enzyme recognises genes product.

Morgan Oatley is one of Australia’s first students to enter the esteemed EMBL International PhD Programme. Read our interview with Morgan about the programming and studying abroad.

Seven years since it started in 2009, the Victorian Life Sciences Computation Initiative (VLSCI) has re-launched as Melbourne Bioinformatics.

The UNSW in collaboration with EMBL Australia are hosting international scientists during a mini-sabbatical to work more closely with the team at the EMBL Australia Node of Single Molecule Science at UNSW. Join us to exchange ideas, develop collaborations, and take advantage of our facilities, which includes a suite of powerful imaging tools.

Throughout 2016 Associate Professor Max Cryle and his collaborators, from the Max Planck Institute for Medical Research, have used published molecular structures of antibiotic resistant golden staph (Staphylococcus aureus), to see how we might overcome the resistance with new super-antibiotics.

The third annual EAPS , entitled -‘Unravelling Nature’s Secrets’, was held (16-18 Nov, 2016) at the South Australia Health and Medical Research Institute (SAHMRI), Adelaide.

Over 200 attendees from all over Australia and the world came together for BioInfoSummer in Adelaide at the end of November 2016 to learn the newest trends and methods in bioinformatics and take this new knowledge and inspiration back to their labs. EMBL Australia was an official supporter of this symposium and the Mäkinen Group from the SA node was involved in its organisation and delivery.

Tanja is a member of the Provis Group at the John Curtin School of Medical Research, at the Australian National University (ANU) where she is in the final stages of her PhD candidacy. Last year, Tanja volunteered to Co-convene EAPS 2016. Her enthusiasm and abundant organisational abilities helped make EAPS 2016 the success it was.

Julienne is a PhD candidate from St Vincent’s Institute for Medical Research and the University of Melbourne where she is a member of Dr Andrew Dean’s team. Julienne is studying the rare and inherited syndrome, Fanconi Anaemia.